ArticleOncoTargets and therapy2024

Combined Silencing of VEGF-A and Angiopoietin-2, a More Effective Way to Inhibit the Ishikawa Endometrial Cancer Cell Line [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.